Mesothelioma Biomarker Could Lead to “Promis...

Posted by

Label: Featured News

Researchers continue to focus on biomarkers as a target to increase the effectiveness of existing treatments for malignant mesothelioma. These genetic characteristics can be used to indicate the progress of mesothelioma, help determine an appropriate treatment, and assess the effectiveness of that treatment. Now, researchers have identified a biomarker that they believe points to poor prognosis in mesothelioma patients, but that could also lead to a promising therapeutic approach for the asbestos-caused cancer. Researchers from Japan report the urokinase-type plasminogen activator receptor (uPAR), also known as CD87, that  is normally expressed th
Read Full Story

Want Specific topic updates?